Logo
E

Evozyne

56 employees

Evozyne designs novel protein therapeutics to solve previously unaddressable patient needs. Show more Show less

Investor insights

Funding rounds participated in

$81M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology

Sectors

Biotechnology

Date founded

2020

Funding rounds raised

Total raised

$81M

from 3 investors over 1 rounds

E

Evozyne raised $81M on October 27, 2023

Investors: Fidelity, OrbiMed and + 3 Other investors

FAQ